Federal Register / Vol. 65, No. 227 / Friday, November 24, 2000 / Notices 70571

Name: CDC Advisory Committee on

HIV and STD Prevention.

Times and Dates: 8:30 a.m.-5 p.m.,

December 14, 2000; 8:30 a.m.-3 p.m.,

December 15, 2000.

Place: Corporate Square Office Park,

Corporate Square

Boulevard, Building 8, 1st Floor

Conference Room, Atlanta,

Georgia 30329.

Status: Open to the public, limited

only by the space available. The meeting

room will accommodate approximately

100 people.

Purpose: This Committee is charged

with advising the Director, CDC,

regarding objectives, strategies, and

priorities for HIV and STD prevention

efforts including maintaining

surveillance of HIV infection, AIDS, and

STDs, the epidemiologic and laboratory

study of HIV/AIDS and STDs,

information/education and risk

reduction activities designed to prevent

the spread of HIV and STDs, and other

preventive measures that become

available.

Matters to be Discussed: Agenda items

include issues pertaining to (1) national

HIV prevention plan, (2) national

syphilis elimination efforts, (3) recent

trends in STD and HIV Morbidity and

Risk Behaviors among MSM, and (4)

issues pertaining to the IOM report on

HIV Prevention. Agenda items are

subject to change as priorities dictate.

Contact Person for More Information:

Paulette Ford, Committee Management

Specialist, National Center for HIV,

STD, and TB Prevention, 1600 Clifton

Road, NE, Mailstop E–07, Atlanta,

Georgia 30333. Telephone 404/639–

8008, fax 404/639–8600, e-mail

pbf7@cdc.gov.

The Director, Management Analysis

and Services Office, has been delegated

the authority to sign Federal Register

Notices pertaining to announcements of

meetings and other committee

management activities, for both the

Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Julia M. Fuller,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention.

[FR Doc. 00–30018 Filed 11–22–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

National Task Force on Fetal Alcohol

Syndrome and Fetal Alcohol Effect:

Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following Federal

advisory committee meeting.

Name: National Task Force on Fetal

Alcohol Syndrome and Fetal Alcohol

Effect (NTFFASFAE).

Times and Dates: 9 a.m.–5 p.m.,

December 14, 2000; 9 a.m.–3 p.m.,

December 15, 2000.

Place: Doubletree Hotel AtlantaBuckhead, 3342 Peachtree Road, NE,

Atlanta, Georgia 30326, telephone 404/

231–1234; fax 404/231–3112.

Status: Open to the public, limited

only by the space available. The meeting

room accommodates approximately 50

people.

Purpose: The Secretary is authorized

by the Public Health Service Act,

Section 399G, (42 U.S.C. 280f, as added

by Pub. L. 105–392) to establish a

National Task Force on Fetal Alcohol

Syndrome and Fetal Alcohol Effect to:

(1) Foster coordination among all

governmental agencies, academic bodies

and community groups that conduct or

support Fetal Alcohol Syndrome (FAS)

and Fetal Alcohol Effect (FAE) research,

programs and surveillance; and (2) to

otherwise meet the general needs of

populations actually or potentially

impacted by FAS and FAE.

Matters To Be Discussed: This is the

initial meeting of the National Task

Force on Fetal Alcohol Syndrome (FAS)

and Fetal Alcohol Effect (FAE). The

Task Force will convene to discuss the

development of defining a national

research agenda on all aspects of public

health research and program

development regarding primary and

secondary prevention activities in the

area of FAS and FAE.

Agenda items are subject to change as

priorities dictate.

Contact Person for More Information:

R. Louise Floyd, DSN, RN, Executive

Secretary, NTFFASFAE, National Center

for Environmental Health, CDC, 4700

Buford Highway, NE, (F–49), Atlanta,

Georgia 30333, telephone 770/488–

7372, fax 770/488–7361.

The Director, Management Analysis

and Services Office, has been delegated

the authority to sign Federal Register

notices pertaining to announcements of

meetings and other committee

management activities for both the CDC

and ATSDR.

Julia M. Fuller,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention.

[FR Doc. 00–29959 Filed 11–22–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Administration for Children and

Families

Proposed Information Collection

Activity; Comment Request

Proposed Projects

Title: AFIA IDA In-depth Participant

Interview.

OMB No.: New Collection.

Description: Part of a Congressionally

mandated evaluation of demonstrations

carried out under AFIA to address the

effects on savings behavior, differential

savings rates, homeownership,

education and self-employment. To

identify lessons to be learned and

whether the program should be made

permanent.

Respondents: AFIA IDA

Demonstration Participants.

ANNUAL BURDEN ESTIMATES

Instrument Number of

respondents

Number of

responses per

respondent

Average burden hours per response Total burden

hours

Participant Survey ........................................... 720 1 40 minutes ......................................................

.67 hours ........................................................

483

Estimated Total Annual Burden Hours .... ........................ ........................ ......................................................................... 483